Eiger Biopharmaceuticals Inc ()

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Propel Bio Management

Leen Kawas And Richard Kayne

146,381 $1,851,720 1.2%
2. 0 $0 0%
3. 0 $0 0%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 7,505,539 $1,684,993 0%
2. 1,820,767 $408,762 0%
3. 583,730 $131,048 0%
4. 379,707 $85,267 0%
5. 338,733 $76,046 0%
News See All